Initial Feasibility Study definition

Initial Feasibility Study means an initial Mineral Reserve estimate and mine plan Former LAC completed on the Cauchari-Olaroz in 2012;
Sample 1Sample 2Sample 3
Initial Feasibility Study means the study and preparation work undertaken by FRESENIUS for TRANSMEDICS pursuant to and under the Letter of Intent.
Sample 1Sample 2Sample 3
Initial Feasibility Study or "Prefeasibility Study" means a study of the feasibility of developing and operating a mine on the Properties, including an analysis of economic, engineering, geological, environmental, regulatory and other considerations, and containing the level of detail customary in the industry to determine whether the veins, ore bodies or other targets identified in Stage I of Earn-in Activities are of sufficient interest to the Parties to proceed with Stage II of Earn-in Activities (with all estimates developed to an accuracy within +/-15%).
Sample 1

Examples of Initial Feasibility Study in a sentence

  • Caltrans prepared the Initial Feasibility Study for Route 102 in 1991 (DKS, 1991).

  • Managing Director Padgette provided an opportunity for the Board to ask questions about the item, as it was brought jointly with Item 3.a, Capital Project Spotlight: Carquinez Crossing Initial Feasibility Study.

  • If upon the completion of an Initial Feasibility Study ASARCO is entitled to become Manager of such Joint Venture and gives required notice then SOTRAPMAG shall be deemed to have resigned as Manager of such Joint Venture and ASARCO shall be deemed to have been appointed as Manager of such Joint Venture on the 30th day following the giving of such notice by ASARCO.

  • The Phase 1 Initial Feasibility Study yielded significant results.

  • Dubai International Financial Centre (DIFC) and Absalon Project (Absalon), a joint venture between affiliates of VP SECURITIES A/S and Soros Fund Management, performed in February 2010 an Initial Feasibility Study in the United Arab Emirates (UAE) with the purpose to investigate whether it is a viable business idea to establish a mortgage solution in the UAE based on the principles behind the Danish Mortgage Model.

  • The Initial Feasibility Study confirmed that a significant number of additional waste cans would be required if the change to LEU was made and the calcination process performed in a controlled manner.

  • Given the near-term lack of wind turbines, unless wind companies have locked in a supply of wind turbines in advance, as some have done, it is difficult to guarantee the availability of a turbine too far in advance of construction.Improving or Eliminating the Initial Feasibility Study: Some have suggested that dropping the initial feasibility study could save time, as the power flow modeling and short circuit analysis is duplicated in greater detail in the system impact study.

  • The initial Program and Budget proposed following contribution of the Mineral Properties shall be (i) supplied by the Manager; (ii) based upon the Initial Feasibility Study; (iii) propose a Development and Mining Program for the Production Area specified therein; (iv) commenced on the effective date of this Agreement, and (v) incorporated herewith as Exhibit E.

  • The provisional PMR Services fees payable to the Management Contractor for the provision of PMR Services for a particular Plot shall be calculated based on (i) 5% of the estimated EPCC Contract Sum; (ii) 5% of the estimated Professional Fees; and (iii) 5% of the estimated Authority and Statutory Charges for that Plot as determined by the Initial Feasibility Study for that Plot and as updated in an Updated Feasibility Study, where applicable.

  • As we have not completely confirmed the capability of the enterprise producing the subject assets, YaChao Appraisal deemed the predictable income generated by the Company through holding the proprietary technologies and the patent as the prospective income of the technical products, which has made reference to the information and data concerning the expected prices and sale volume of the relevant products as stated in the Initial Feasibility Study Report.


More Definitions of Initial Feasibility Study

Initial Feasibility Study means, in relation to a particular proposal for a management agreement, a study carried out by an approved person to determine whether it is reasonable to proceed with a full feasibility study;
Sample 1
Initial Feasibility Study means a Feasibility Study prepared for either of the Joint Ventures in respect of a Primary Deposit on either the Paul Isnard Concessions or the Eau Blanche Permits which reaches one of the following conclusions:
Sample 1
Initial Feasibility Study means the Feasibility Study delivered pursuant to Section 5.5 of the Earn-in Agreement.
Sample 1

Related to Initial Feasibility Study

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Generation Interconnection Feasibility Study means a study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Tariff, Part IV, section 36.

  • Firm Transmission Feasibility Study means a study conducted by the Transmission Provider in accordance with Tariff, Part II, section 19.3 and Tariff, Part III, section 32.3.

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Development Phase means the period before a vehicle type is type approved.

  • Mitigation Study Period means the duration of time extending six consecutive Capability Periods and beginning with the Starting Capability Period associated with a Class Year Study, Additional SDU Study, and/or Expedited Deliverability Study. For purposes of Section 23.4.5 of this Attachment H, “Mitigated UCAP” shall mean one or more megawatts of Unforced Capacity that are subject to Control by a Market Party that has been identified by the ISO as a Pivotal Supplier. For purposes of Section 23.4.5 of this Attachment H, “Mitigation Net CONE” shall mean the capacity price on the currently effective ICAP Demand Curve for the Mitigated Capacity Zone corresponding to the average amount of excess capacity above the Mitigated Capacity Zone Installed Capacity requirement, expressed as a percentage of that requirement, that formed the basis for the ICAP Demand Curve approved by the Commission.

  • Development Report means a written account of Licensee’s progress under the Development Plan having at least the information specified on Appendix B to this Agreement, and shall be sent to the address specified on Appendix B.

  • Phase II Clinical Trial means a study in humans of the safety, dose ranging and efficacy of a product, which is prospectively designed to generate sufficient data (if successful) to commence a Phase III Clinical Trial or to file for accelerated approval, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(b) or its foreign equivalents.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Study Completion means the database for the Study has been locked and all Essential Documents have been provided to the Sponsor, including a copy of the letter from the Reviewing HREC acknowledging receipt of the final report and/or closure letter from the Principal Investigator.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Development Plan has the meaning set forth in Section 3.2.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Clinical Study means a Xxxxx 0 Xxxxx, Xxxxx 2 Study, Phase 3 Study, Post-Marketing Study, Supplemental Study or other study (including a non-interventional study) in humans to obtain information regarding the product, including information relating to the safety, tolerability, pharmacological activity, pharmacokinetics, dose ranging or efficacy of the product.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.